Suppr超能文献

通过分析血清肿瘤标志物水平评估手术结果及预测预后:对甲状腺髓样癌患者验证的一种理论建议

[Evaluation of surgical results and prediction of prognosis by analysis of serum tumor marker levels: proposal of a theory tested on patients with medullary thyroid carcinoma].

作者信息

Miyauchi A

机构信息

2nd Dept. of Surgery, Kagawa Medical School.

出版信息

Gan No Rinsho. 1988 May;34(6):739-43.

PMID:3379756
Abstract

A theory to evaluate the benefit of surgery and to predict the prognosis in patients with a malignant tumor by analysis of serum tumor marker levels is proposed, and an analysis of 67 patients with a medullary thyroid carcinoma is reported as an example of its application. This theory incorporates the following concepts: the tumor marker doubling time, the reduction index, the expected prolongation of survival by surgical therapy, and the expected duration of survival after surgery. These parameters allow a quantitative judgement of the surgical therapy and a quantitative prediction of the subsequent prognosis as demonstrated in patients with a medullary thyroid carcinoma.

摘要

提出了一种通过分析血清肿瘤标志物水平来评估手术益处并预测恶性肿瘤患者预后的理论,并报告了对67例甲状腺髓样癌患者的分析作为其应用实例。该理论包含以下概念:肿瘤标志物倍增时间、降低指数、手术治疗预期延长的生存期以及术后预期生存期。这些参数能够对手术治疗进行定量判断,并对后续预后进行定量预测,如在甲状腺髓样癌患者中所示。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验